Journal
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH
Volume 13, Issue 6, Pages 403-410Publisher
INFORMA HEALTHCARE
DOI: 10.1080/10623320601061656
Keywords
angiogenesis; atherosclerosis; cell therapy; endothelial progenitor cell; vasculogenesis
Categories
Ask authors/readers for more resources
The identification of circulating endothelial progenitor cells (EPCs) has prompted ail explosion of interest in postnatal vasculogenesis and the role of this mechanism in human health and disease. Previously considered restricted to the embryonic phase, the differentiation in situ of progenitor cells to vascular endothelium is now known to occur in the adult. A role for EPCs in the modulation of angiogenesis has also been recognized. These cells are enriched in the mononuclear cell fraction of peripheral blood but have also been isolated from bone marrow, the vessel wall, and a number of other organs and tissues. Accumulating data suggest ail important vasculoprotective function for EPCs, although a maladaptive role underpinning a variety of angiogenesis-dependent diseases is also being investigated. Encouraging results observed with experimental and early human trials of EPC-based regenerative therapies have further underscored the significance of this recently discovered cell type. Notwithstanding the scope and pace of these developments, a number of challenges remain: the precise ontogeny and lineage of these cells is unknown, the true extent to which EPCs participate in neovascularization and vascular repair is still uncertain, and the efficacy of EPC-based regenerative therapies has yet to be proven in randomized controlled trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available